Cargando…
Albumin and multiple sclerosis
Leakage of the blood–brain barrier (BBB) is a common pathological feature in multiple sclerosis (MS). Following a breach of the BBB, albumin, the most abundant protein in plasma, gains access to CNS tissue where it is exposed to an inflammatory milieu and tissue damage, e.g., demyelination. Once in...
Autor principal: | LeVine, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828783/ https://www.ncbi.nlm.nih.gov/pubmed/27067000 http://dx.doi.org/10.1186/s12883-016-0564-9 |
Ejemplares similares
-
Aspirin and multiple sclerosis
por: Tsau, Sheila, et al.
Publicado: (2015) -
Iron chelation and multiple sclerosis
por: Weigel, Kelsey J., et al.
Publicado: (2014) -
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017) -
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
por: LeVine, Steven M.
Publicado: (2016) -
Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
por: Biswas, Sangita, et al.
Publicado: (2012)